Caris expands its extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine by welcoming the University of Hawai'i Cancer Center IRVING, Texas , Aug. 19, 2024 /PRNewswire/ -- Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that the University of Hawai'i Cancer Center (UH Cancer Center) has joined the Caris Precision Oncology AllianceTM (Caris POA). The Caris POA is a growing network of leading cancer centers and research consortia across the globe that collaborate to advance precision oncology and biomarker-driven research, with its members working together to establish and optimize standards of care for molecular testing through innovative research to improve clinical outcomes for cancer patients.
POA members are uniquely positioned to leverage Caris' highly sophisticated AI bioinformatics and machine learning capabilities across Caris' massive multi-modal database to enable innovative research to improve clinical outcomes for cancer patients. The UH Cancer Center, an organized research unit within the University of Hawaiʻi at Mānoa, is one of only 72 research organizations in the U.S.
designated by the National Cancer Institute, and the only one in Hawaiʻi and the Pacific. With a history of over five decades, the UH Cancer Center is housed in a world-class facility built in 2013 in Honolulu , with 300 research faculty, sta.